At a Glance
Taiwan Resonant Waves Research Corp.(TRWR) was founded in 2010 in the capital of Taiwan – Taipei. Integrating innovative bioelectronic technology with medical devices, we are dedicated to helping patients with chronic diseases better manage health-related challenges.
There is unlimited promise in the application of bioelectronic medicine in the treatment of chronic diseases. Designed and developed by TRWR, Microcurrent Electrical Nerve Stimulation technology (MENS) is currently being used as a non-invasive, physical approach to treating and alleviating symptoms associated with diabetes mellitus.
Our vision is to lead the world in groundbreaking research and development in electroceutical technology as a means of enhancing quality of life, without the adverse side effects of conventional approaches.
We are committed to addressing the unmet medical needs of those suffering from chronic diseases by pursuing advancements in bioelectronic technology and delivering cost-effective healthcare solutions.
Our vision is to establish global presence as a Taiwanese brand through strategic collaborations and partnerships around the world. We strive to continually advance our core competences in Diabetes-MENS technology and expand our patent portfolio.
Innovation is no happenstance; it is the product of courage, perseverance, opportunity, and responsibility.
From Johannes Kepler to Sir Isaac Newton, the path to innovation is one that is filled with delight, toil, glory, and blessing.